NIH study shows hyaluronan is effective in treating chronic lung disease
Naturally produced by the body, hyaluronan represents a new class of biologic that significantly improves lung health in patients with...


CF PharmTech and Chengdu Shangyi ...
CF PharmTech and Chengdu Shangyi Launch the "Home-Based Recovery Program for Discharged Covid-19 Patients" and Announce Today's Global...


CF Patients and Families Favoring Telehealth as Option for Care, Survey Finds
People with cystic fibrosis (CF) and their families are largely satisfied with the convenience and quality of care received using...


AzurRx BioPharma Announces First Two Patients Dosed in Phase 2b OPTION 2 Extension Study of MS1819
DELRAY BEACH, Fla., Jan. 21, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company...
Study Examines Effects of Socioeconomics on Health of Youngsters
Children with cystic fibrosis (CF) who live in more socioeconomically disadvantaged areas of the U.S. tend to have worse lung function...


Cholesterol Metabolism Impaired in CF Mouse Model
The metabolism of cholesterol is impaired in a mouse model of cystic fibrosis, a preliminary study suggests. In the model, there seems to...


Inhaled-IV Antibiotic Combo May Better Treat Acute Flares Than IV-only Mix
When given alongside the antibiotic Colistin (colistimethate), Cayston (aztreonam lysine), an inhaled antibiotic specifically targeting...


Study Examines Effects of Socioeconomics on Health of Youngsters
Children with cystic fibrosis (CF) who live in more socioeconomically disadvantaged areas of the U.S. tend to have worse lung function...


New strategy to accelerate diagnosis and improve treatment of rare diseases
Rare Disease Framework sets out vision to improve the lives of more than 3.5 million people with rare diseases in the UK The framework...
Small Study Shows Tobramycin Safely Treats Lung Infection in Infants With CF
Inhaled antibiotic tobramycin safely eradicated early Pseudomonas aeruginosa infection in cystic fibrosis (CF) patients younger than a...

